Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 5.94% | $1.81M | $1.03T | 35.66% | 72 Outperform | |
| Cardinal Health | 5.24% | $1.59M | $48.11B | 66.56% | 66 Neutral | |
| Rentokil Initial | 5.04% | $1.53M | $15.89B | 34.27% | 66 Neutral | |
| UnitedHealth | 5.03% | $1.53M | $311.59B | -33.39% | 72 Outperform | |
| Waste Management | 4.95% | $1.50M | $87.77B | 5.12% | 76 Outperform | |
| Chubb | 4.54% | $1.38M | $123.18B | 21.45% | 80 Outperform | |
| Johnson & Johnson | 4.51% | $1.37M | $495.71B | 44.83% | 78 Outperform | |
| Microsoft | 4.50% | $1.37M | $3.55T | 14.12% | 79 Outperform | |
| McKesson | 4.47% | $1.36M | $100.55B | 40.03% | 62 Neutral | |
| Coca-Cola | 4.16% | $1.26M | $298.40B | 13.59% | 75 Outperform |